0001493152-22-034686.txt : 20221207 0001493152-22-034686.hdr.sgml : 20221207 20221207090143 ACCESSION NUMBER: 0001493152-22-034686 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221205 FILED AS OF DATE: 20221207 DATE AS OF CHANGE: 20221207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUFFOLO ROBERT R CENTRAL INDEX KEY: 0001187308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38630 FILM NUMBER: 221449233 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001614067 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320074500 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 983 UNIVERSITY AVENUE, BLDG. B CITY: LOS GATOS STATE: CA ZIP: 95032 BUSINESS PHONE: (408) 385-1742 MAIL ADDRESS: STREET 1: 983 UNIVERSITY AVENUE, BLDG. B CITY: LOS GATOS STATE: CA ZIP: 95032 4 1 ownership.xml X0306 4 2022-12-05 0 0001614067 Aridis Pharmaceuticals, Inc. ARDS 0001187308 RUFFOLO ROBERT R C/O ARIDIS PHARMACEUTICALS, INC. 983 UNIVERSITY AVE, BLDG. B LOS GATOS, CA 95032 1 0 0 0 Restricted Stock Units 2022-12-05 4 A 0 10000 0 A Common Stock 10000 10000 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. 5,000 shares of Common Stock will vest on June 5, 2023 and 5,000 will vest on 12/5/2023. /s/ Robert Ruffolo 2022-12-07